1
|
Mansour S, Mekaouche FZN, Rouabah H, Brahim S, Boudia F, Yafour N, Bereksi Reguig F, Toumi H. Comprehensive medication management (CMM): Application of a new pharmaceutical practice in onco-hematology. Ann Pharm Fr 2024:S0003-4509(24)00068-3. [PMID: 38729518 DOI: 10.1016/j.pharma.2024.05.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2023] [Revised: 04/20/2024] [Accepted: 05/04/2024] [Indexed: 05/12/2024]
Abstract
The integration of a large number of drugs, such as antineoplastic agents and cancer-related supportive care drugs, into the management of cancer patients exposes them to an increased number of drug-related problems (DRP). Clinical pharmacists contribute to drug management by actively intervening in detected DRP. The aim of this study is to assess the impact of the applying a clinical pharmacist-driven comprehensive medication management (CMM) service to onco-hematology patients. This prospective interventional study was carried out over six-month duration, specifically from November 06, 2022 to April 5, 2023 in the oncology and hematology departments of the EHU Oran. The adherence to treatment was evaluated using the 8-item Morisky Medication Adherence Scale (MMAS). Whereas data related to the patient's general condition and medication history was assessed using the Pharmaceutical Care Network Europe (PCNE) Classification for Drug-Related Problems V9.1. Among the 130 patients included in the study, a total of 879 DRP were identified, with a mean of 6.78 (±1.72) DRP/patient, half of which were related to efficacy (51%). Almost half of our sample (44.6%) did not adhere to their treatment. The most frequent cause of DRP, accounting for (19.9%) of the cases, was the inappropriate administration by a health professional. A total of 875 pharmaceuticals interventions (PI) were proposed, 67.2% of which were focused at the drug level. The PI acceptance rate was 94.1%. The integration of CMM services in onco-hematology played an important role in optimizing dosing regimen and treatment administration methods, as well as preventing iatropathology in the management of cancer patients.
Collapse
Affiliation(s)
- Sabah Mansour
- Faculty of Medicine of Oran, Oran, Algeria; Pharmacovigilance service, EHU Oran, Oran, Algeria.
| | | | - Halima Rouabah
- Faculty of Medicine of Oran, Oran, Algeria; Pharmacovigilance service, EHU Oran, Oran, Algeria.
| | | | - Fatima Boudia
- Faculty of Medicine of Oran, Oran, Algeria; Pharmacovigilance service, EHU Oran, Oran, Algeria.
| | - Nabil Yafour
- Faculty of Medicine of Oran, Oran, Algeria; Hematology department, EHU Oran, Oran, Algeria
| | - Faiza Bereksi Reguig
- Faculty of Medicine of Oran, Oran, Algeria; Oncology department, EHU Oran, Oran, Algeria
| | - Houari Toumi
- Faculty of Medicine of Oran, Oran, Algeria; Pharmacovigilance service, EHU Oran, Oran, Algeria.
| |
Collapse
|
2
|
Fournier A, Fallet C, Sadeghipour F, Perrottet N. Assessing the applicability and appropriateness of ChatGPT in answering clinical pharmacy questions. Ann Pharm Fr 2024; 82:507-513. [PMID: 37992892 DOI: 10.1016/j.pharma.2023.11.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2023] [Revised: 11/16/2023] [Accepted: 11/16/2023] [Indexed: 11/24/2023]
Abstract
OBJECTIVES Clinical pharmacists rely on different scientific references to ensure appropriate, safe, and cost-effective drug use. Tools based on artificial intelligence (AI) such as ChatGPT (Generative Pre-trained Transformer) could offer valuable support. The objective of this study was to assess ChatGPT's capacity to correctly respond to clinical pharmacy questions asked by healthcare professionals in our university hospital. MATERIAL AND METHODS ChatGPT's capacity to respond correctly to the last 100 consecutive questions recorded in our clinical pharmacy database was assessed. Questions were copied from our FileMaker Pro database and pasted into ChatGPT March 14 version online platform. The generated answers were then copied verbatim into an Excel file. Two blinded clinical pharmacists reviewed all the questions and the answers given by the software. In case of disagreements, a third blinded pharmacist intervened to decide. RESULTS Documentation-related issues (n=36) and drug administration mode (n=30) were preponderantly recorded. Among 69 applicable questions, the rate of correct answers varied from 30 to 57.1% depending on questions type with a global rate of 44.9%. Regarding inappropriate answers (n=38), 20 were incorrect, 18 gave no answers and 8 were incomplete with 8 answers belonging to 2 different categories. No better answers than the pharmacists were observed. CONCLUSIONS ChatGPT demonstrated a mitigated performance in answering clinical pharmacy questions. It should not replace human expertise as a high rate of inappropriate answers was highlighted. Future studies should focus on the optimization of ChatGPT for specific clinical pharmacy questions and explore the potential benefits and limitations of integrating this technology into clinical practice.
Collapse
Affiliation(s)
- A Fournier
- Service of Pharmacy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
| | - C Fallet
- Service of Pharmacy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
| | - F Sadeghipour
- Service of Pharmacy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland; School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland; Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
| | - N Perrottet
- Service of Pharmacy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland; School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland.
| |
Collapse
|
3
|
Le Joncour S, Gohier P, Rombaut F, Soulet C, Maachi I, Xuereb F. [The clinical pharmacist, an essential element in the new gradation of care for ambulatory patients]. Ann Pharm Fr 2024; 82:351-358. [PMID: 38070707 DOI: 10.1016/j.pharma.2023.12.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2023] [Revised: 10/16/2023] [Accepted: 12/04/2023] [Indexed: 12/18/2023]
Abstract
OBJECTIVE Pharmaceutical presence in oncology allows the clinical pharmacist to integrate tripartite consultations for primary prescription of oral anticancer drugs. The aim of the study is to describe the deployment of the clinical pharmacy activity in 2 oncology departments since its implementation in 2019, to assess the financial gain of the pharmaceutical interventions through the new gradation of outpatient management published on September 10, 2020, and finally to assess their satisfaction following the deployment of this pathway. METHOD A retrospective study was conducted to collect pricing data for oral therapy interviews in patients between January 2019 and December 2022. To complement this, a satisfaction survey was conducted by the oral therapy pharmaceutical team between 01/01/2022 and 12/31/2022 among patients undergoing treatment. RESULTS 579 patients received a targeted pharmaceutical interview as part of the oral therapy patient pathway. The average invoiced amount of a pharmaceutical consultation carried out as part of a tripartite first prescription was 355.44 euros. The 579 patients who benefited from a targeted pharmaceutical interview generated a revenue of 87,545 euros for the hospital. In terms of evaluating patient satisfaction, 163 usable responses were received out of 267 patients questioned, representing a response rate of 61%, with an overall score of 9.1/10. CONCLUSION Pending the introduction of a specific remuneration for clinical pharmacy activities, the valuation of tripartite consultations is a lever for financing clinical pharmacy activities in hospitals.
Collapse
Affiliation(s)
- S Le Joncour
- Pharmacie à usage intérieur, CHU de Bordeaux, hôpital Haut-Lévêque, 33600 Pessac, France; Service d'oncologie digestive, CHU de Bordeaux, hôpital Haut-Lévêque, 33600 Pessac, France.
| | - P Gohier
- Pharmacie à usage intérieur, CHU de Bordeaux, hôpital Haut-Lévêque, 33600 Pessac, France; Service d'oncohématologie, CHU de Bordeaux, hôpital Haut-Lévêque, 33600 Pessac, France
| | - F Rombaut
- Service d'oncohématologie, CHU de Bordeaux, hôpital Haut-Lévêque, 33600 Pessac, France
| | - C Soulet
- Service d'oncologie digestive, CHU de Bordeaux, hôpital Haut-Lévêque, 33600 Pessac, France
| | - I Maachi
- Pharmacie à usage intérieur, CHU de Bordeaux, hôpital Haut-Lévêque, 33600 Pessac, France
| | - F Xuereb
- Pharmacie à usage intérieur, CHU de Bordeaux, hôpital Haut-Lévêque, 33600 Pessac, France; University Bordeaux, Inserm, biologie des maladies cardiovasculaires, U1034, 33600 Pessac, France
| |
Collapse
|
4
|
Capelle H, Baldin C, Caunes P, Pons I, Meguerditchian C, Argenson JN, Daumas A, Hache G. [Validation of the French version of the Assessment Tool for Hospital Admissions Related to Medications (AT-HARM10) to detect drug-related hospitalizations]. Therapie 2023:S0040-5957(23)00183-X. [PMID: 38008600 DOI: 10.1016/j.therap.2023.10.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2023] [Revised: 09/05/2023] [Accepted: 10/12/2023] [Indexed: 11/28/2023]
Abstract
Admissions of the elderly related to medication errors are frequent in hospital, more than half would be avoidable, but there is currently no validated method in French to identify them. The objective of this work was to validate the French version of the AT-HARM10 tool in order to use it for patients admitted in our healthcare facilities. The tool has 10 questions. A positive response to any of the first 3 questions identify admissions that are unlikely to be drug-related. A positive response to one of the following 7 questions identify possible medication-related admissions. For semantic and linguistic validation, we performed cross-validation with forward-backward translation. To clinically validate the method, we conducted a retrospective study including patients over 65 admitted to short-stay units (UHCD) and to orthopedic surgery units in two French hospitals. Two hundred and sixty-six (266) patients were included ; 166 patients admitted to UHCD (mean age 86.0±5.7 years; sex ratio 0.66; mean number of drugs prescribed 7.7±3.8) and 100 patients admitted to orthopedic units (mean age 85.2±6.1 years; sex ratio 0.43; mean number of prescribed drugs 6.4±3.6). We identified 55 % of admissions probably related to medication in UHCD and 76 % in orthopedic units (p<0.05). The most represented item was P5 in both groups (Might [side] effects of the medications the patient was taking [prescribed or not prescribed] prior to hospitalization have caused the admission [including over-treatment] ? The validated AT-HARM10 tool is now integrated into our clinical pharmacy practices and medication reviews are offered as a priority to patients admitted for iatrogenic reasons.
Collapse
Affiliation(s)
| | - Coralie Baldin
- PUI, centre hospitalier d'Aubagne, 13400 Aubagne, France
| | - Pierre Caunes
- Equipe mobile de gériatrie, Assistance publique Hôpitaux de Marseille, 13005 Marseille, France
| | - Isabelle Pons
- Pole urgences-médecine, centre hospitalier d'Aubagne 13400, Aubagne, France
| | | | - Jean-Noël Argenson
- AP-HM, hospitalisation chirurgie orthopédique Sud, 13005 Marseille, France
| | - Aurélie Daumas
- AP-HM, Service de médecine interne-gériatrie et thérapeutique, 13005 Marseille, France
| | - Guillaume Hache
- Aix Marseille université, APHM, hôpital de la Timone, service de pharmacie, 13005 Marseille, France
| |
Collapse
|
5
|
Kabac T, Le Tohic S, Spadoni S. [Medication reconciliation on admission: One year of practice in health care institutions during the COVID-19 pandemic]. Ann Pharm Fr 2023; 81:863-874. [PMID: 36731628 PMCID: PMC9886383 DOI: 10.1016/j.pharma.2023.01.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2022] [Revised: 01/11/2023] [Accepted: 01/20/2023] [Indexed: 02/02/2023]
Abstract
OBJECTIVES Medication reconciliation is a key point of the v2020 certification. The main objective of this study was to evaluate this activity over one year, including the first epidemic wave at COVID-19. The secondary objectives were to identify the obstacles and levers and to evaluate doctor satisfaction. METHODS This was a retrospective study of drug reconciliations performed on admission during 12 months of the emergence of COVID-19. Patients aged 65 years and older from orthopedic and visceral surgery, acute hospitalization and conventional medicine units were included. Unintentional discrepancies were analyzed. The obstacles and levers were identified by means of a focus group. Doctors' satisfaction was collected using online quiz. RESULTS A total of 760 patients were conciliated, of which 27% (n=208) by hospital pharmacy technicians. A decrease in activity was observed during the first epidemic wave. An unintentional discrepancy was found in 77% of patients, and only 48% were corrected by the prescriber. These results were impacted by the pandemic. The pharmaceutical team was mobilized in the logistical management of the crisis, but it was able to adapt in order to perpetuate the activity. Doctors are satisfied with the process. CONCLUSIONS Medication reconciliation on admission is essential for the prevention of iatrogeny, particularly with the impact of the COVID-19 pandemic in healthcare institutions.
Collapse
Affiliation(s)
- T Kabac
- Service de pharmacie, hôpital d'instruction des armées Laveran, 34, boulevard Laveran, 13013 Marseille, France.
| | - S Le Tohic
- Service de pharmacie, hôpital d'instruction des armées Laveran, 34, boulevard Laveran, 13013 Marseille, France
| | - S Spadoni
- Service de pharmacie, hôpital d'instruction des armées Laveran, 34, boulevard Laveran, 13013 Marseille, France
| |
Collapse
|
6
|
Correard F, Arcani R, Montaleytang M, Nakache J, Berard C, Couderc AL, Villani P, Daumas A. [Medication reconciliation: Interests and limits]. Rev Med Interne 2023; 44:479-486. [PMID: 36841717 DOI: 10.1016/j.revmed.2023.02.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2022] [Revised: 01/22/2023] [Accepted: 02/05/2023] [Indexed: 02/26/2023]
Abstract
Admission to hospital is a critical transition point for the continuity of care in medication management. Medication reconciliation can identify and resolve errors due to inaccurate medication histories. The practice of medication reconciliation is securing for the patient because of the medication errors detected with significant clinical impact. Its implementation must comply with the recommendations of the French National Authority for Health (HAS) and its deployment is now integrated into the contract for improving the quality and efficiency of care (CAQES). However, although it allows to intercept medication errors, its impact on the length of hospitalization, the rate of readmission and/or death following discharge seems limited. Given the limited human resources to carry out this time-consuming activity, patient prioritization should be considered. Studies on the fate of patients and on the medico-economic issues are also necessary in order to make this activity sustainable.
Collapse
Affiliation(s)
- F Correard
- Pôle pharmacie, unité d'expertise pharmaceutique et recherche biomédicale, hôpital de la Timone, Assistante Publique des Hôpitaux de Marseille (AP-HM), Marseille, France
| | - R Arcani
- Service de médecine interne, gériatrie et thérapeutique du PR Villani, hôpital de la Timone, Assistante Publique des Hôpitaux de Marseille (AP-HM), Marseille, France
| | - M Montaleytang
- Pôle pharmacie, unité d'expertise pharmaceutique et recherche biomédicale, hôpital de la Timone, Assistante Publique des Hôpitaux de Marseille (AP-HM), Marseille, France
| | - J Nakache
- Pôle pharmacie, unité d'expertise pharmaceutique et recherche biomédicale, hôpital de la Timone, Assistante Publique des Hôpitaux de Marseille (AP-HM), Marseille, France
| | - C Berard
- Pôle pharmacie, unité d'expertise pharmaceutique et recherche biomédicale, hôpital de la Timone, Assistante Publique des Hôpitaux de Marseille (AP-HM), Marseille, France
| | - A L Couderc
- Service de médecine interne, gériatrie et thérapeutique du PR Villani, hôpital Sainte Marguerite, Assistante Publique des Hôpitaux de Marseille (AP-HM), Marseille, France
| | - P Villani
- Service de médecine interne, gériatrie et thérapeutique du PR Villani, hôpital de la Timone, Assistante Publique des Hôpitaux de Marseille (AP-HM), Marseille, France; Service de médecine interne, gériatrie et thérapeutique du PR Villani, hôpital Sainte Marguerite, Assistante Publique des Hôpitaux de Marseille (AP-HM), Marseille, France
| | - A Daumas
- Service de médecine interne, gériatrie et thérapeutique du PR Villani, hôpital de la Timone, Assistante Publique des Hôpitaux de Marseille (AP-HM), Marseille, France.
| |
Collapse
|
7
|
Coiffard J, Aubry A, Bleibtreu A, Fourniols E, Junot H. Impact of clinical pharmacist interventions in a bone and joint infection orthoseptic surgery unit. Ann Pharm Fr 2023; 81:826-832. [PMID: 37075975 DOI: 10.1016/j.pharma.2023.04.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2022] [Revised: 02/09/2023] [Accepted: 04/13/2023] [Indexed: 04/21/2023]
Abstract
OBJECTIVES To assess the impact of interventions of a clinical pharmacist in a unit of orthopedic surgery specialized in bone and joint infections. METHODS Daily, in routine, a clinical pharmacist analyzed medication prescribed to inpatients via a computerized physician order entry (CPOE) (Phedra software). His attention was particularly focused on the impact of antibiotics on other medications. For this study, all of the pharmacist interventions (PI) have been retrospectively collected, then anonymized, and assessed over a two-month period. RESULTS Thirty-eight patients were hospitalized during the study period, with a mean age of 63 years old. Forty-five interventions were identified which represents a mean of 1.18 pharmaceutical interventions per patient. Most of them concerned lack of follow-up (24%) and drug-drug interactions (22%) and widely non-anti-infectious medication (35 interventions) with levothyroxine (10 interventions) as the most involved non-anti-infectious molecule. Among antibiotics, with respectively 9 and 8 interventions, rifampicin and fluoroquinolones (6 interventions for moxifloxacin) were the most concerned notably for drug-drug interactions with usual treatment. CONCLUSION In this observational retrospective study, 1.18 pharmacist interventions (PI) per patient were observed. Most of them are lack of follow-up and drug-drug interactions especially with usual treatment of patients. Moxifloxacin and rifampicin were the most antibiotics involved. Patients' characteristics (older, polypharmacy), long-term hospitalization and surgery are known to be predictive factors of medication errors and this study highlights the importance of the presence of clinical pharmacist in orthopedic surgery wards.
Collapse
Affiliation(s)
- Julie Coiffard
- Department of pharmacy, Pitié-Salpêtrière Hospital, Paris, France.
| | - Alexandra Aubry
- Laboratory of bacteriology, Pitié-Salpêtrière Hospital, Paris, France
| | - Alexandre Bleibtreu
- Infectious and tropical diseases ward, Pitié-Salpêtrière Hospital, Paris, France
| | - Eric Fourniols
- Orthopaedic surgery ward, Pitié-Salpêtrière Hospital, Paris, France
| | - Helga Junot
- Department of pharmacy, Pitié-Salpêtrière Hospital, Paris, France
| |
Collapse
|
8
|
Baudouin A, Guillemin MD, Rioufol C, Ranchon F, Parat S. [SARS-COV-2 pandemic: Involvement of the hospital pharmacist in securing patient care]. Ann Pharm Fr 2023; 81:900-908. [PMID: 37086966 PMCID: PMC10118052 DOI: 10.1016/j.pharma.2023.04.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2022] [Revised: 03/31/2023] [Accepted: 04/18/2023] [Indexed: 04/24/2023]
Abstract
OBJECTIVES In the context of the SARS-CoV-2 pandemic, hospital pharmacists supported the implementation of recommendations and ensured the safety of patient medication management. The aim of this study is to establish the interest of the involvement of the hospital pharmacist in this context by describing and comparing the activities carried out with patients with COVID-19 and those without. METHODS During the study period, data on clinical pharmacy activities with hospitalized patients were collected and analyzed: pharmaceutical analysis of prescriptions, participation in multi-professional consultation meetings (RCP) dedicated to COVID-19, and monitoring of adverse events. RESULTS The activities concerned 1483 patients, including 444 with COVID-19, resulting in 575 pharmaceutical interventions (PI). The main problems identified were overdoses, untreated indications, and drug-drug interactions (DDI). AMIs were significantly more common in patients with COVID-19, with 73.3% involving disease-specific therapies. Eleven PIs had a life-threatening impact, 189 a major impact. During the PCRs, 36 PIs were performed for 59% of the patients presented. A pharmacovigilance report was performed for a quarter of patients treated with hydroxychloroquine and 33% of patients treated with lopinavir/ritonavir. CONCLUSIONS This study demonstrates the value of involving hospital pharmacists in the drug management of patients with COVID-19, particularly with the evolution of available therapies and the implementation of vaccination, in order to reduce the spread of SARS-COV2 and limit the appearance of resistance.
Collapse
Affiliation(s)
- Amandine Baudouin
- Pharmacie à usage intérieur, hôpital Lyon Sud, hospices civils de Lyon, groupement hospitalier Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite cedex, France.
| | - Marie-Delphine Guillemin
- Pharmacie à usage intérieur, hôpital Lyon Sud, hospices civils de Lyon, groupement hospitalier Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite cedex, France
| | - Catherine Rioufol
- Pharmacie à usage intérieur, hôpital Lyon Sud, hospices civils de Lyon, groupement hospitalier Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite cedex, France; EMR3738, université de Lyon, Lyon, France
| | - Florence Ranchon
- Pharmacie à usage intérieur, hôpital Lyon Sud, hospices civils de Lyon, groupement hospitalier Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite cedex, France; EMR3738, université de Lyon, Lyon, France
| | - Stéphanie Parat
- Pharmacie à usage intérieur, hôpital Lyon Sud, hospices civils de Lyon, groupement hospitalier Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite cedex, France
| |
Collapse
|
9
|
Cormier N, Bedoucha C, Roux-Marson C, Valery A, Dufossez F. [The "Gradation instruction" of care: An opportunity to integrate clinical pharmacy activities in the cancer patient journey]. Bull Cancer 2023:S0007-4551(23)00135-2. [PMID: 36959042 DOI: 10.1016/j.bulcan.2023.02.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2022] [Revised: 02/04/2023] [Accepted: 02/10/2023] [Indexed: 03/25/2023]
Abstract
The ten-year cancer control strategy launched in 2021 highlights the structuring of supportive care as a strong axis to limit the side effects of treatments and simplify the patient's journeys. On the other hand, the "Gradation instruction" published in 2020, introduced new invoicing rules for outpatient hospital wards, which facilitates the coordinated interventions of several health professionals (medical, paramedical, or socio-educational) around patients. Among these professionals, the pharmacist has a particular role, inside the multidisciplinary oncology teams, since cancer oral therapies require therapeutic adherence and a continuum of care with retail pharmacists. Until now, these clinical pharmaceutical activities, which include carrying out medication reviews, developing personalized pharmaceutical plans and conducting pharmaceutical interviews with patients, have struggled to develop in a sustainable manner due to a lack of funding in hospitals. Finally, the "gradation instruction" represents a real opportunity to support clinical pharmacy actions, particularly in outpatient hospital wards. In order to save time for hospital teams wishing to initiate or consolidate these activities, we should consider points of vigilance and facilitating factors.
Collapse
Affiliation(s)
- Nicolas Cormier
- CHU de Nantes, Service pharmacie, 5, allées de l'île Gloriette, 44093 Nantes cedex 1, France.
| | - Clément Bedoucha
- Centre hospitalier de Libourne, Service pharmacie, 112, rue de la Marne, 33500 Libourne, France
| | - Clarisse Roux-Marson
- CHU Nîmes - OMEDIT Occitanie, Service pharmacie, place du Professeur-Debré, 30029 Nîmes cedex 9, France
| | - Antoine Valery
- Hôpital de La Source, Orléans et GHT Hôpitaux publics du Loiret, CHR Orléans La Source, 14, avenue de l'Hôpital, BP 6709, 45067 Orléans Cedex 2, France
| | - François Dufossez
- GHT ARTOIS. Centre hospitalier de Béthune, rue Delbecque, BP 10-809, 62408 Béthune cedex, France
| |
Collapse
|
10
|
Fulcrand J, Delvoye-Heiremans J, Lemaire A. [Optimal pain management for cancer patients with chronic renal failure]. Bull Cancer 2023:S0007-4551(23)00031-0. [PMID: 36732141 DOI: 10.1016/j.bulcan.2022.12.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Revised: 12/01/2022] [Accepted: 12/08/2022] [Indexed: 02/01/2023]
Abstract
The management of multimorphic cancer pain is a major supportive care in oncology, for which many national and international recommendations have recently been updated. Any cancer patient must benefit from access to supportive care from the diagnosis, throughout the entire care pathway. Chronic renal failure, from any etiology, requires special attention and constant attention to details from interdisciplinary caregivers' teams to propose the best analgesic therapeutic strategy, combining complementary and interventional approaches to treatments. Analgesic therapies, in particular opioids and antineuropathics, require specific precautions. A therapeutic alliance integrating clinical pharmacy as a supportive care in its own right, is a major asset allowing the optimization and securing of analgesic drug treatments, conditioning both their efficacy, their tolerance and therapeutic observance, in the goal of improving the patient's quality of life.
Collapse
Affiliation(s)
- Julie Fulcrand
- UF pharmacie clinique, pôle cancérologie & spécialités médicales, centre hospitalier de Valenciennes, Valenciennes, France
| | - Julie Delvoye-Heiremans
- UF pharmacie clinique, pôle cancérologie & spécialités médicales, centre hospitalier de Valenciennes, Valenciennes, France
| | - Antoine Lemaire
- Département interdisciplinaire de soins de support pour le patient oncologique, pôle cancérologie & spécialités médicales, centre hospitalier de Valenciennes, Valenciennes, France.
| |
Collapse
|
11
|
Décaudin B, Voirol P, Perrottet N, Spinewine A, Bussières JF. [Clinical pharmacy in four French-speaking university hospitals, integration and supervision of clinical pharmacists: An exploratory study]. Ann Pharm Fr 2023; 81:138-151. [PMID: 35952847 DOI: 10.1016/j.pharma.2022.08.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2022] [Revised: 06/30/2022] [Accepted: 08/01/2022] [Indexed: 01/07/2023]
Abstract
BACKGROUND Pharmacy practice continues to evolve worldwide. The clinical role of the pharmacists is increasingly recognized and their integration into the health care team is irreversible. Despite this progress, there are still a wide disparity in the scope of practice provided by hospital pharmacists around the world. This disparity can be attributed to a variety of factors. OBJECTIVES The primary objective is to describe the organization of clinical pharmacy in four university hospitals in four French-speaking countries. The secondary objective is to identify similarities and differences and to identify perspectives for the future. METHODS This is an exploratory cross-sectional descriptive study. The study targeted a university hospital (CHU) in France, Belgium, Switzerland and Canada (Quebec). A volunteer expert pharmacist involved in the management of clinical pharmacy at each hospital was approached at the initiative of a team member. A working group of five pharmacists was set up. RESULTS During the year 2021, the group met virtually on ten occasions. Although all institutions have an academic mission, they have very different numbers of beds and volumes of activity. The number of pharmacists is also very different (0.83 FTE pharmacist/1000 admissions in Belgium, 0.22 in France, 0.59 in Switzerland and 2.39 in Quebec). In all countries, pharmacists provide clinical pharmacy services to patients in a centralised or decentralised manner, including, to various extent, prescription analysis, medication reconciliation, pharmaceutical interviews and discharge plans. CONCLUSIONS Clinical pharmacy practice is very heterogeneous in a selection of four French-speaking teaching hospitals. Identification of similarities and differences may inspire improvements in the organization of clinical pharmacy activity. This work has contributed to the establishment of a community of practice on clinical pharmacy in the French-speaking world.
Collapse
Affiliation(s)
- B Décaudin
- Université de Lille, CHU de Lille, ULR 7365-GRITA-Groupe de recherche sur les formes injectables et les technologies associées, 59000 Lille, France; CHU de Lille, institut de pharmacie, 59000 Lille, France.
| | - P Voirol
- Service de pharmacie, centre hospitalier universitaire vaudois et université de Lausanne, Lausanne, Suisse; Institut des sciences pharmaceutiques de Suisse occidentale, université de Genève, université de Lausanne, Lausanne, Suisse
| | - N Perrottet
- Service de pharmacie, centre hospitalier universitaire vaudois et université de Lausanne, Lausanne, Suisse; Institut des sciences pharmaceutiques de Suisse occidentale, université de Genève, université de Lausanne, Lausanne, Suisse
| | - A Spinewine
- Clinical Pharmacy Research Group, université catholique de Louvain, Louvain Drug Research Institute, Bruxelles, Belgique; CHU UCL Namur, site Godinne, département de pharmacie, Yvoir, Belgique
| | - J-F Bussières
- Unité de recherche en pratique pharmaceutique, département de pharmacie, CHU Sainte-Justine, Montréal, Québec, Canada; Faculté de pharmacie, université de Montréal, Montréal, Québec, Canada
| |
Collapse
|
12
|
Blin M, Cherel A, Bouglé C, Piriou G. [Definition and evaluation of a multidisciplinary patient's pharmacotherapy management method: The pharmaceutical care plan]. Ann Pharm Fr 2023; 81:13-29. [PMID: 35724711 DOI: 10.1016/j.pharma.2022.06.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2021] [Revised: 04/08/2022] [Accepted: 06/14/2022] [Indexed: 01/07/2023]
Abstract
The implementation of pharmaceutical monitoring as defined by the Council of Europe in its Resolution of March 2020 requires defining for each patient, objectives and a treatment plan, to share, monitor and update them in a manner coordinated, interprofessional and in partnership with the patient. It recognizes the central place of the pharmacist by encompassing all of its clinical pharmacy activities and emphasizes the need for interprofessional collaboration (Hepler CD, Strand LM. Opportunities and Responsibilities in Pharmaceutical Care. American Journal of Hospital Pharmacy. Mars 1990; 47(3): 533-543). This work first presents the pharmaceutical care plan as a multiprofessional methodology that meets the objectives of pharmaceutical monitoring, then in a second step its evaluation through two regional projects. The pharmaceutical care plan unites, around the patient, all the actors involved in their pharmacotherapy, throughout their care path. It makes it possible to control the iatrogenic drug risk and includes the patient's drug management with regard to curative, preventive and palliative objectives and in a global strategy for the care and promotion of patient health. This methodology is integrated into coordinated exercise strategies and care pathway approaches. Several levers will help support its deployment, such as inter-professional education and digital health tools.
Collapse
Affiliation(s)
- M Blin
- Observatoire du médicament des dispositifs médicaux et de l'innovation thérapeutique de Bretagne, 14 bis, avenue Yves-Thépot, 29107 Quimper, France.
| | - A Cherel
- Observatoire du médicament des dispositifs médicaux et de l'innovation thérapeutique de Normandie, Espace Claude Monet, 2, place Jean-Nouzille, 14000 Caen, France
| | - C Bouglé
- Observatoire du médicament des dispositifs médicaux et de l'innovation thérapeutique de Normandie, Espace Claude Monet, 2, place Jean-Nouzille, 14000 Caen, France
| | - G Piriou
- Observatoire du médicament des dispositifs médicaux et de l'innovation thérapeutique de Bretagne, 14 bis, avenue Yves-Thépot, 29107 Quimper, France
| |
Collapse
|
13
|
Barbier A, Rousselière C, Robert L, Cousein E, Décaudin B. [Development of a methodological guide on the implementation of a pharmaceutical decision support system: Feedback from a French university hospital]. Ann Pharm Fr 2023; 81:163-172. [PMID: 35792150 DOI: 10.1016/j.pharma.2022.06.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2022] [Revised: 05/25/2022] [Accepted: 06/29/2022] [Indexed: 01/07/2023]
Abstract
OBJECTIVE Develop a methodological guide on the implementation of a PDSS (pharmaceutical decision support system). METHOD Observational study, retrospective conducted at Lille University Hospital from May 2017 to December 2020, corresponding to the period of implementation and then use of the software. The different phases of the project are described as well as the methodology at each stage. RESULTS Four stages seem necessary for the establishment of the PDSS: reflection and preparation of the project, contracting, implementation, use and evaluation. Based on these results and our experience, in particular the difficulties encountered, a methodological diagram of the various steps necessary for the implementation of a PDSS is proposed. CONCLUSION The establishment of a PDSS, especially in the field of clinical pharmacy, is a long multidisciplinary process. Several steps, from project preparation to production start-up are necessary. Planning the different stages is essential for the proper implementation of the SADP so that the installation is as efficient as possible.
Collapse
Affiliation(s)
- A Barbier
- CHU Lille, Institut de Pharmacie, 59000 Lille, France.
| | - C Rousselière
- CHU Lille, Institut de Pharmacie, 59000 Lille, France
| | - L Robert
- CHU Lille, Institut de Pharmacie, 59000 Lille, France
| | - E Cousein
- CHU Lille, Institut de Pharmacie, 59000 Lille, France
| | - B Décaudin
- Université Lille, CHU Lille, ULR 7365-GRITA, Groupe de Recherche sur les formes Injectables et les Technologies Associées, 59000 Lille, France
| |
Collapse
|
14
|
Valentin B, Laueriere C, Rousseliere C, Bruandet A, Odou P, Theis D, Decaudin B. [Standardized computer recording of clinical pharmacy procedures in health care institution: Feedback and evaluation of potential economic value]. Ann Pharm Fr 2023; 81:115-122. [PMID: 35952848 DOI: 10.1016/j.pharma.2022.08.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2022] [Revised: 06/17/2022] [Accepted: 08/01/2022] [Indexed: 01/07/2023]
Abstract
Clinical pharmacy procedures are clearly defined by the French society of clinical pharmacy. However, clinical pharmacists do not have efficient tools for their traceability. This need has increased following the publication of the instruction on the day hospital management of patients. Indeed, the action of the clinical pharmacist is included in it. In order to improve our traceability of clinical pharmacy acts and to take advantage of the implementation of the instruction, we worked with the medical information department to integrate our activity into their business software and to model the pathways valued by the intervention of the clinical pharmacist in outpatient care and in day hospital.
Collapse
Affiliation(s)
- B Valentin
- Institut de Pharmacie, CHU de Lille, 59000 Lille, France.
| | - C Laueriere
- Département d'Information Médicale, CHU de Lille, 59000 Lille, France
| | - C Rousseliere
- Institut de Pharmacie, CHU de Lille, 59000 Lille, France
| | - A Bruandet
- Département d'Information Médicale, CHU de Lille, 59000 Lille, France
| | - P Odou
- Institut de Pharmacie, CHU de Lille, 59000 Lille, France; University Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, 59000 Lille, France
| | - D Theis
- Département d'Information Médicale, CHU de Lille, 59000 Lille, France
| | - B Decaudin
- Institut de Pharmacie, CHU de Lille, 59000 Lille, France; University Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, 59000 Lille, France
| |
Collapse
|
15
|
Clairet AL, Berthou J, Koeberlé S, Bertrand X, Nerich V, Limat S. [What academic training for pharmacy students for clinical pharmacy? Example of shared medication report]. Ann Pharm Fr 2021; 80:374-382. [PMID: 34314681 DOI: 10.1016/j.pharma.2021.07.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2020] [Revised: 06/22/2021] [Accepted: 07/19/2021] [Indexed: 10/20/2022]
Abstract
OBJECTIVES In 2018, the implementation of shared medication reports in pharmacy encourages pharmacists to cooperate with other healthcare professionals. This job allows a decrease of medication errors in elderly. This requires a reorganization of the training offered by universities (initial and continuing training). The aim is to present the results of this pedagogical experimentation. METHODS The experimentation (years 2017-2018 and 2018-2019) required the creation of a course to allow students to carry out a pharmaceutical analysis suitable to elderly people, to set up and carry out a shared medication report in pharmacy. Then, during their 6th year internship, students had to carry out at least one shared medication report per month. A monthly follow-up was organized with a database online. RESULTS Sixty-four students and 35 internship supervisors participated in the experimentation. All the students improved their ease in using clinical pharmacy tools (pharmaceutical analysis, pharmaceutical interventions, assessment of adherence, etc.). They carried out 345 shared medication reports. In 24.3% of cases, an improvement in the prescription was proposed to the doctor (general practitioner or specialist). For 80% of the internship supervisors, the initial training of the students helped to set up this new pharmacy activity. CONCLUSIONS This teaching is appreciated by students and internship supervisors. It enabled the adoption of the various tools essential for carrying out shared medication reports in pharmacy. Shared medication reports reinforce the multidisciplinary work of pharmacists, especially with general practitioners.
Collapse
Affiliation(s)
- A L Clairet
- Pôle Pharmaceutique, CHU de Besançon, 3 bd Fleming, 25030 Besançon Cedex, France; INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon- Hôte-Tumeur/Ingénierie Cellulaire et Génique, Université Bourgogne Franche Comté, 25030 Besançon Cedex, France.
| | - J Berthou
- Pôle Pharmaceutique, CHU de Besançon, 3 bd Fleming, 25030 Besançon Cedex, France
| | - S Koeberlé
- Service de gériatrie, CHU de Besançon, 3, boulevard Alexandre Fleming, 25030 Besançon Cedex, France; Equipe « Ethique et Progrès Médical », Inserm, CIC 1431, CHU, F-25000, Besançon, France
| | - X Bertrand
- Hygiène Hospitalière, CHU de Besançon, 3 bd Fleming, 25030 Besançon Cedex, France; UMR CNRS 6249 Chrono-environnement, Université Bourgogne Franche Comté, 25030 Besançon Cedex, France
| | - V Nerich
- Pôle Pharmaceutique, CHU de Besançon, 3 bd Fleming, 25030 Besançon Cedex, France; INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon- Hôte-Tumeur/Ingénierie Cellulaire et Génique, Université Bourgogne Franche Comté, 25030 Besançon Cedex, France
| | - S Limat
- Pôle Pharmaceutique, CHU de Besançon, 3 bd Fleming, 25030 Besançon Cedex, France; INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon- Hôte-Tumeur/Ingénierie Cellulaire et Génique, Université Bourgogne Franche Comté, 25030 Besançon Cedex, France
| |
Collapse
|
16
|
Masse M, Douzé L, Perez M, Cuvelier E, Henry H, Odou P, Pelayo S, Décaudin B. [Evaluation of the training of clinical pharmacy residents in prescription analysis using an ergonomic approach]. Ann Pharm Fr 2021; 80:187-199. [PMID: 33992642 DOI: 10.1016/j.pharma.2021.05.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2020] [Revised: 04/26/2021] [Accepted: 05/06/2021] [Indexed: 10/21/2022]
Abstract
OBJECTIVES To perform an ergonomic intervention using the methodology of the analysis of the activity of the training process of clinical pharmacy residents in the analysis of prescriptions. METHODS The evaluation was carried out over two semesters: from May to October 2016 (first study) and from November 2016 to April 2017 (second study). The interviews and observations were conducted by an ergonomist who is an expert in this type of evaluation. The first study was based on observations of the training process and interviews at different time. The second study allowed to support pharmacists and evaluate the changes following the recommendations of the previous study. RESULTS A total of 6 and 9 residents participated in the first and second study, respectively. During the first study, 6 difficulties were raised which allowed implementation decisions. Feedback from residents on the training process was generally positive for the first part of the training but negative for the last part. The average number of fears expressed by the residents was higher at the beginning (2.9 fears) than at the end (1 fear). CONCLUSIONS The training process has been adapted to the expectations and feelings of the residents. Follow-up at the beginning and throughout the internship was essential. The next stage of this work will be to evaluate the contribution of the dashboards for monitoring clinical pharmacy skills in the new degree for hospital pharmacy.
Collapse
Affiliation(s)
- M Masse
- ULR 7365 - GRITA - groupe de Recherche sur les formes injectables et les technologies associées, université de Lille, CHU de Lille, 59000 Lille, France.
| | - L Douzé
- Inserm, CIC-IT/Evalab 1403 - centre d'investigation clinique, EA 2694, université de Lille, CHU de Lille, 59000 Lille, France
| | - M Perez
- CHU de Lille, institut de pharmacie, 59000 Lille, France
| | - E Cuvelier
- ULR 7365 - GRITA - groupe de Recherche sur les formes injectables et les technologies associées, université de Lille, CHU de Lille, 59000 Lille, France
| | - H Henry
- ULR 7365 - GRITA - groupe de Recherche sur les formes injectables et les technologies associées, université de Lille, CHU de Lille, 59000 Lille, France
| | - P Odou
- ULR 7365 - GRITA - groupe de Recherche sur les formes injectables et les technologies associées, université de Lille, CHU de Lille, 59000 Lille, France
| | - S Pelayo
- Inserm, CIC-IT/Evalab 1403 - centre d'investigation clinique, EA 2694, université de Lille, CHU de Lille, 59000 Lille, France
| | - B Décaudin
- ULR 7365 - GRITA - groupe de Recherche sur les formes injectables et les technologies associées, université de Lille, CHU de Lille, 59000 Lille, France
| |
Collapse
|
17
|
Duval M, Satori D, Al Wazzan N, Chidiac A, Lao S. [Medical reconciliation for hospitalized patients in orthopedic surgery department: Return of experience over 2 years of practice]. Ann Pharm Fr 2021:S0003-4509(21)00044-4. [PMID: 33785371 DOI: 10.1016/j.pharma.2021.03.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2020] [Revised: 03/16/2021] [Accepted: 03/18/2021] [Indexed: 11/20/2022]
Abstract
OBJECTIVES Some medication errors can be prevented by pharmacist action such as medication reconciliation. The main objective of this study was to evaluate the medication reconciliation activity after two years of practice. The secondary objective was to assess the medical staff's satisfaction following the setting up of the activity. METHODS This retrospective study was realized over a period of two years in our hospital. Patients meeting the following criteria were included: 65 years and over, hospitalized in orthopedic surgery department, preferentially after a discharge of the emergency room. After the best possible medication history was established, it is compared to medicines ordered. The discrepancies were defined as intended or unintended. Study data were collected and analyzed using Excel and SPSS statistics®. RESULTS A total of 899 patients met the inclusion criteria during the study period, mean age was 78 years (27; 104). A total of 84 % of our cohort was admitted after a discharge of the emergency room. Seventy five percent of the population had at least an unintended discrepancie, a mean of 2,3 unintended discrepancies per patient was identified. Seventy five percent of the unintended discrepancy were discussed and resolved. The medical staff was mostly satisfied of the activity. CONCLUSION The medication reconciliation secured the drug management of hospitalized patients.
Collapse
|
18
|
Tanty A, Dantigny R, Bardet JD, Chanoine S, Bedouch P, Allenet B. [French hospital clinical pharmacy: an identity crisis?]. Ann Pharm Fr 2021; 79:431-9. [PMID: 33309602 DOI: 10.1016/j.pharma.2020.11.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2020] [Revised: 11/23/2020] [Accepted: 11/26/2020] [Indexed: 11/24/2022]
|
19
|
Lattard C, Orsini C, Fuss D, Chenailler C, Gondé H, Hervouët C, Varin R. [Optimising drug dispensation by pharmacy technicians: A quality approach]. Ann Pharm Fr 2020; 79:207-215. [PMID: 33098874 DOI: 10.1016/j.pharma.2020.10.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2020] [Revised: 09/07/2020] [Accepted: 10/13/2020] [Indexed: 10/23/2022]
Abstract
INTRODUCTION In a context of continuity of quality improvement, we are committed to enhancing the care management and medication management of outpatients in the drug dispensation unit of our pharmacy. An audit was carried out to assess the training needs of pharmacy technicians (PTs). MATERIALS AND METHODS All drug dispensations done over a 9-week period by the units PTs were audited. Data collected were: PTs' presentation to the patient, duration of drug dispensation, notion of introduction or renewal, the tools used during retrocession, and the explanations given to the patient about her/his treatment. PT perceptions and patient satisfaction were evaluated on a Likert scale from 1 to 5 and on a scale from 1 to 4, respectively. RESULTS One hundred drug dispensation were audited: 21 introductions and 79 renewals. Tools were used in 52% of introductions and 11% of renewals. Administration modalities were explained for all introductions but for only 57% of renewals, 47% of adverse events and 9.5% of storage methods. Tolerance was discussed in 34% of drug dispensations and compliance in 19%. The scores of PT perception and patient satisfaction were 4.4/5 and between 3/4 and 3.9/4 depending on the items, respectively. CONCLUSION Several areas for improvement are highlighted in this survey. PTs' complementary should include communication with outpatients. This approach is an integral part of the ISO 9001 certification obtained in 2019 in our drug dispensation unit.
Collapse
Affiliation(s)
- C Lattard
- Service pharmacie, centre hospitalier universitaire de Rouen, 1, rue de Germont, 76000 Rouen, France.
| | - C Orsini
- Service pharmacie, centre hospitalier universitaire de Rouen, 1, rue de Germont, 76000 Rouen, France
| | - D Fuss
- Service pharmacie, centre hospitalier universitaire de Rouen, 1, rue de Germont, 76000 Rouen, France
| | - C Chenailler
- Service pharmacie, centre hospitalier universitaire de Rouen, 1, rue de Germont, 76000 Rouen, France
| | - H Gondé
- Service pharmacie, centre hospitalier universitaire de Rouen, 1, rue de Germont, 76000 Rouen, France; Inserm UMR 1.2.3.4 : Physiopathologie, Autoimmunité, maladies Neuromusculaires et THErapies Régénératrices (PANTHER), faculté mixte de médecine et de pharmacie de Rouen, 76000 Rouen, France
| | - C Hervouët
- Service pharmacie, centre hospitalier universitaire de Rouen, 1, rue de Germont, 76000 Rouen, France
| | - R Varin
- Service pharmacie, centre hospitalier universitaire de Rouen, 1, rue de Germont, 76000 Rouen, France; Inserm UMR 1.2.3.4 : Physiopathologie, Autoimmunité, maladies Neuromusculaires et THErapies Régénératrices (PANTHER), faculté mixte de médecine et de pharmacie de Rouen, 76000 Rouen, France
| |
Collapse
|
20
|
Lemtiri J, Matusik E, Cousein E, Lambiotte F, Elbeki N. The role of the critical care pharmacist during the COVID-19 pandemic. Ann Pharm Fr 2020; 78:464-468. [PMID: 33038310 PMCID: PMC7540194 DOI: 10.1016/j.pharma.2020.09.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2020] [Revised: 09/09/2020] [Accepted: 09/18/2020] [Indexed: 02/07/2023]
Abstract
The COPIL allowed the restructuring of the ICU in record time to double its capacity. The CCP, integrated in the COPIL and already a member of the ICU team for a few years, provided an essential link between the ICU and the pharmacy during the COVID-19 pandemic. The CCP implemented actions to avoid health products shortages, to secure practices and played a key role in the critical analysis of emerging published data in COVID-19 potential treatments.
On January 4 2020, the World Health Organization (WHO) reported the emergence of a cluster of pneumonia cases in Wuhan, China due to a new coronavirus, the SARS-CoV-2. A few weeks later, hospitals had to put in place a series of drastic measures to deal with the massive influx of suspected COVID-19 (COronaroVIrus Disease) patients while securing regular patient care, in particular in the intensive care units (ICU). Since March 12th, 77 of the 685 COVID-19 patients admitted to our hospital required hospitalization in the ICU. What are the roles and the added-value of the critical care pharmacist during this period? His missions have evolved although they have remained focused on providing health services for the patients. Indeed, integrated into a steering committee created to organize the crisis in the intensive care units, the role of the clinical pharmacist was focused on the organization and coordination between ICU and the pharmacy, the implementation of actions to secure practices, to train new professionals and the adaptation of therapeutic strategies. He participated to literature monitoring and increased his involvement in the clinical research team. He provided a link between the ICU and the pharmacy thanks to his knowledges of practices and needs.
Collapse
Affiliation(s)
- J Lemtiri
- Intensive care unit, Valenciennes general hospital, 114, avenue Desandrouin, 59300 Valenciennes, France.
| | - E Matusik
- Intensive care research and department of pharmacy, Valenciennes general hospital, 114, avenue Desandrouin, 59300 Valenciennes, France
| | - E Cousein
- Department of pharmacy, Valenciennes general hospital, 114, avenue Desandrouin, 59300 Valenciennes, France
| | - F Lambiotte
- Intensive care unit, Valenciennes general hospital, 114, avenue Desandrouin, 59300 Valenciennes, France
| | - N Elbeki
- Department of anesthesia, valenciennes general hospital, 114, avenue Desandrouin, 59300 Valenciennes, France
| |
Collapse
|
21
|
Leherle A, Kowal C, Toulemon Z, Dalle-Pecal M, Pelissolo A, Leboyer M, Paul M, Diviné C. [Is the medication reconciliation achievable and relevant in Psychiatry?: Feedback on the implementation of medication reconciliation on hospital admission]. Ann Pharm Fr 2019; 78:252-263. [PMID: 31796266 DOI: 10.1016/j.pharma.2019.10.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2019] [Revised: 10/25/2019] [Accepted: 10/30/2019] [Indexed: 10/25/2022]
Abstract
OBJECTIVE The health care pathway of patients suffering from mental disorders is complex and includes a risk of interruption of treatment. We implemented medication reconciliation at patients' admission to mental health care service in February 2017. The aim of this study was to achieve a feedback experience answering our questions about the feasibility and relevance of this process. METHOD A prospective analysis of medication reconciliations over the first 7 months of implementation was carried out according to 3 activity indicators and 6 performance indicators. RESULTS A total of 39 patients were reconciled and 56.4 % of them were in enforced hospitalization unit. All patients were interviewed by the pharmacist. Collected information during this interview was concordant with at least one of the other sources in 70.4 % of the cases. Thirteen patients were not reconciled within 72h after their admission because of their psychiatric pathology. The average number of unintentional medication discrepancy (UMD) detected was 0.97 per reconciled patient. The rate of major gravity UMD was 23.7 %. The number of UMDs per patient was significantly higher in enforced hospitalization unit (P<0.05). UMDs were essentially related to somatic drugs (81.6 %). Nearly 95 % of the detected UMDs resulted in a modification of prescription. CONCLUSION These results show that medication reconciliation at patients' admission is feasible and relevant in psychiatry. To limit constraints related to psychiatric pathology, we propose to perform medication reconciliation of patients more than 72 hours after patient admission provided that their clinical condition allows it.
Collapse
Affiliation(s)
- A Leherle
- Service pharmacie hôpital Albert-Chenevier, hôpitaux universitaires Henri-Mondor AP-HP, 40, rue de Mesly, 94000 Créteil, France.
| | - C Kowal
- Service pharmacie hôpital Albert-Chenevier, hôpitaux universitaires Henri-Mondor AP-HP, 40, rue de Mesly, 94000 Créteil, France.
| | - Z Toulemon
- Service pharmacie hôpital Albert-Chenevier, hôpitaux universitaires Henri-Mondor AP-HP, 40, rue de Mesly, 94000 Créteil, France.
| | - M Dalle-Pecal
- Service pharmacie hôpital Albert-Chenevier, hôpitaux universitaires Henri-Mondor AP-HP, 40, rue de Mesly, 94000 Créteil, France.
| | - A Pelissolo
- Pôle de psychiatrie, hôpitaux universitaires Henri-Mondor AP-HP, 40, rue de Mesly 94000 Créteil, France.
| | - M Leboyer
- Pôle de psychiatrie, hôpitaux universitaires Henri-Mondor AP-HP, 40, rue de Mesly 94000 Créteil, France.
| | - M Paul
- Service pharmacie, hôpitaux universitaires Henri-Mondor AP-HP, 51, avenue du Maréchal de Lattre de Tassigny, 94000 Créteil, France.
| | - C Diviné
- Service pharmacie hôpital Albert-Chenevier, hôpitaux universitaires Henri-Mondor AP-HP, 40, rue de Mesly, 94000 Créteil, France.
| |
Collapse
|
22
|
Painchart L, Drancourt P, Aubert J, Inghels Y, Boyer J. [Interest and difficulties in setting up pharmaceutical reconciliations for patients with dressings for complex wounds]. Ann Pharm Fr 2019; 77:516-531. [PMID: 31255240 DOI: 10.1016/j.pharma.2019.06.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2019] [Revised: 03/23/2019] [Accepted: 06/03/2019] [Indexed: 11/29/2022]
Abstract
OBJECTIVES The management of wounds is a commonplace activity in a patient's healthcare pathway. The involvement of the pharmacist in the management of complex dressings can help strengthen the continuity of this care thanks to the pharmaceutical reconciliation. The objective of this study was to improve the quality of information transmitted between the city and the hospital regarding complex wound dressings. METHODS This is a prospective study consisting of two groups in three services (medicine, diabetology, vascular surgery): the control group corresponded to a classic patient care and in the intervention group, the pharmacists performed dressing reconciliations. A follow-up of the patients after coming back home was realized with healthcare professionals of city involved. RESULTS Twenty patients were included in the control group and 19 in the intervention group. Entry conciliation has improved the quality and quantity of information on wounds transmitted between the city and the hospital. Exit conciliation has increased from 60 to 100% wound and dressing output prescriptions. One hundred percent of nurses surveyed were satisfied with the patients care. CONCLUSIONS Reconciliation would improve information transmitted between the city and the hospital and avoid a break in the continuity of complex wounds cares. However, the time dedicated and the adhesion of the care services were difficulties encountered. This study is the first highlighting the interest of medical device reconciliation and could allow reconciliation extension toward other medical devices.
Collapse
Affiliation(s)
- L Painchart
- Service dispositifs médicaux, pôle pharmacie, centre hospitalier de Valenciennes, 59000 Valenciennes, France.
| | - P Drancourt
- Service dispositifs médicaux, pôle pharmacie, centre hospitalier de Valenciennes, 59000 Valenciennes, France
| | - J Aubert
- Service dispositifs médicaux, pôle pharmacie, centre hospitalier de Valenciennes, 59000 Valenciennes, France
| | - Y Inghels
- Service dispositifs médicaux, pôle pharmacie, centre hospitalier de Valenciennes, 59000 Valenciennes, France
| | - J Boyer
- Service dispositifs médicaux, pôle pharmacie, centre hospitalier de Valenciennes, 59000 Valenciennes, France
| |
Collapse
|
23
|
Duwez M, Valette A, Foroni L, Allenet B. [Involvement of hospital pharmacy technician for expanding medication reconciliation process in France: Actors' willingness and opinions]. Ann Pharm Fr 2019; 77:168-177. [PMID: 30678804 DOI: 10.1016/j.pharma.2018.11.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2018] [Revised: 11/12/2018] [Accepted: 11/17/2018] [Indexed: 10/27/2022]
Abstract
OBJECTIVES Medication reconciliation is widely promoted by international health authorities. Its expansion requires human resources, which are limited and unequally distributed among health care facilities. Recent international studies support the involvement of pharmacy technician in the medication reconciliation process but his role remains unstructured in France. We aimed to assess pharmacy technicians' opinions and willingness to be involved in the medication reconciliation process expansion and to identify the levers and barriers of the project. METHODS A field study was conducted among health facilities of our territory hospital group. Semi-structured interviews were carried out with different pharmacy technicians. Data were analyzed using a qualitative thematic analysis approach. RESULTS Overall, 12 pharmacy technicians from 5 hospitals were interviewed and almost all assumed their rightful place in the medication reconciliation process (n=11), with a view to revaluating tasks. For all pharmacy technicians, the main barriers to participate in medication reconciliation were the lack of time and training. The spread of a "patient culture", the supervision by pharmacists, the desire to be part of the care team in the ward and additional training requests were major levers of change. CONCLUSIONS Pharmacy technicians' role in expanding medication reconciliation process is legitimate and must be standardized in France. The deployment of the project requires to be formalized within a territory and should consider and develop local organisations.
Collapse
Affiliation(s)
- M Duwez
- Pharmacie, CHU Grenoble Alpes, 38700 La Tronche, France; Université Grenoble Alpes/CNRS/TIMC - IMAG UMR5525/Themas, 38700 La Tronche, France
| | - A Valette
- Université Grenoble Alpes/CNRS/CERAG, 38000 Grenoble, France
| | - L Foroni
- Pharmacie, CHU Grenoble Alpes, 38700 La Tronche, France
| | - B Allenet
- Pharmacie, CHU Grenoble Alpes, 38700 La Tronche, France; Université Grenoble Alpes/CNRS/TIMC - IMAG UMR5525/Themas, 38700 La Tronche, France.
| |
Collapse
|
24
|
Allenet B, Lehmann A, Baudrant M, Gauchet A. [We have to stop talking about "non compliant" patients but rather about patients with difficulties of medication adherence]. Ann Pharm Fr 2018; 76:489-498. [PMID: 30196933 DOI: 10.1016/j.pharma.2018.07.006] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2018] [Revised: 07/10/2018] [Accepted: 07/23/2018] [Indexed: 10/28/2022]
Abstract
Medication adherence can be defined as the link between "what the patient implements" and "what the patient and his doctor have decided together after negotiating without constrains". This definition should be put into perspective with the chronology of the disease and the way the patient experiences it. Counselling actions should always be adapted to the situation and negotiated with the patient, all along the process of care. This article proposes a model for this process and offers options pour tailored counselling. Key elements for pharmacist's practice are: simplify the prescription; communicate with the patient according to his stage of acceptation of the disease; get adequate training for motivational interviewing.
Collapse
Affiliation(s)
- B Allenet
- Pôle pharmacie, UF pharmacie clinique, unité transversale d'éducation du patient de l'Arc Alpin, CHU de Grenoble, université Grenoble-Alpes, ThEMAS TIMC-IMAG (UMR CNRS 5525), CS 10217, 38043 Grenoble Cedex 9, France.
| | - A Lehmann
- Pôle pharmacie, UF pharmacie clinique, unité transversale d'éducation du patient de l'Arc Alpin, CHU de Grenoble, université Grenoble-Alpes, ThEMAS TIMC-IMAG (UMR CNRS 5525), CS 10217, 38043 Grenoble Cedex 9, France
| | - M Baudrant
- Pôle pharmacie, UF pharmacie clinique, unité transversale d'éducation du patient de l'Arc Alpin, CHU de Grenoble, université Grenoble-Alpes, ThEMAS TIMC-IMAG (UMR CNRS 5525), CS 10217, 38043 Grenoble Cedex 9, France
| | - A Gauchet
- Laboratoire inter universitaire de psychologie, PC2S, EA 4145, université Grenoble-Alpes, 38400 Saint Martin d'Hères, France
| |
Collapse
|
25
|
Jarre C, Bouchet J, Hellot-Guersing M, Leromain AS, Derharoutunian C, Gadot A, Roubille R. [Targeted pharmacist-led medication order review in hospital: Assessment of a selection method for drug prescriptions]. Ann Pharm Fr 2017; 75:463-472. [PMID: 28760311 DOI: 10.1016/j.pharma.2017.07.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2017] [Revised: 06/30/2017] [Accepted: 07/03/2017] [Indexed: 11/26/2022]
Abstract
OBJECTIVES The aim of this study was to assess a selection method for drug prescriptions developed at the hospital level that allows to target pharmacist-led medication order review for at-risk patients and drugs. METHODS A one-month study has been conducted on all targeted medication orders in 19 care units. Selection criteria have been identified: biological criteria, alert medications and drug interactions. Pharmacists' interventions proposed during medication order review were listed and the possible links to the selection criteria were determined. RESULTS A total of 1612 prescriptions were analysed and 236 pharmacists' interventions were performed (14.6 interventions per 100 prescriptions). Physicians' acceptance rate was 60.6%. The percentage of pharmacists' interventions linked to the selection criteria was 35.6%. The relevance of the biological criteria was identified, particularly the one identifying patients with creatinine clearance below 30ml/min. Six alert medications were also relevant selection criteria: dabigatran, morphine, gentamicin, methotrexate, potassium chloride and trimethoprim sulfamethoxazole. Drug interactions criteria was irrelevant. CONCLUSIONS This study allowed a first assessment of the selection criteria used. A largest study seems necessary to continue the analysis of this selection method for prescriptions, especially the assessment of the alert medications list, in order to refine the prescriptions targeting.
Collapse
Affiliation(s)
- C Jarre
- Service pharmacie, centre hospitalier Lucien-Hussel, montée du Docteur-Chapuis, 38200 Vienne, France.
| | - J Bouchet
- Service pharmacie, centre hospitalier Lucien-Hussel, montée du Docteur-Chapuis, 38200 Vienne, France
| | - M Hellot-Guersing
- Service pharmacie, centre hospitalier Lucien-Hussel, montée du Docteur-Chapuis, 38200 Vienne, France
| | - A-S Leromain
- Service pharmacie, centre hospitalier Lucien-Hussel, montée du Docteur-Chapuis, 38200 Vienne, France
| | - C Derharoutunian
- Service pharmacie, centre hospitalier Lucien-Hussel, montée du Docteur-Chapuis, 38200 Vienne, France
| | - A Gadot
- Service pharmacie, centre hospitalier Lucien-Hussel, montée du Docteur-Chapuis, 38200 Vienne, France
| | - R Roubille
- Service pharmacie, centre hospitalier Lucien-Hussel, montée du Docteur-Chapuis, 38200 Vienne, France
| |
Collapse
|
26
|
Jennings P, Lotito A, Baysson H, Pineau-Blondel E, Berlioz J. [Clinical pharmacy: Evaluation of physician's satisfactions and expectations in a French regional hospital]. Ann Pharm Fr 2016; 75:144-151. [PMID: 27769515 DOI: 10.1016/j.pharma.2016.08.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2016] [Revised: 06/01/2016] [Accepted: 08/10/2016] [Indexed: 11/25/2022]
Abstract
INTRODUCTION The purpose of the study was to evaluate physician's satisfaction with the clinical pharmacy activities in a French regional hospital. METHODS Data were collected by face-to-face interviews carried out by a public health intern with physicians from 14 different departments of medicine and surgery. A specifically designed questionnaire was used for this study. This contained 18 closed-ended questions, 3 open-ended questions and 6 questions relating to the multidisciplinary analysis of prescriptions of elderly patients. RESULTS The questionnaire was proposed to 78 physicians, of which 62 replied (participation rate of 79%). Thirty-seven percent were interns (23/62), 19% were assistants (12/62) and 44% were senior physicians (27/62). Clinical pharmacy satisfaction levels were generally very high. In regard to clinical skills, 87% of the physicians were satisfied with pharmacists' competencies and 91% by the pertinence of transmitted information. Ninety-five percent of the physicians were also satisfied by the logistical aspect and the relationship with pharmacists (reactivity, availability and communication). Analysis of the open-ended questions showed that physicians were in favour of the increased presence of clinical pharmacists on the wards. CONCLUSIONS This study shows a high level of physician satisfaction in relation to the clinical pharmacy activities in our hospital, and should be viewed as a strong endorsement of the work of the clinical pharmacy. This study highlights some areas of improvement such as increase presence of the clinical pharmacists on the wards. In order to assess periodically our activity, this study must be repeated in the future.
Collapse
Affiliation(s)
- P Jennings
- Service d'information et d'évaluation médicale, 74370 Metz-Tessy, France; Centre hospitalier Annecy-Genevois, 21, impasse des Ilettes, 74370 Metz-Tessy, France
| | - A Lotito
- Pharmacie à usage intérieur, France; Centre hospitalier Annecy-Genevois, 21, impasse des Ilettes, 74370 Metz-Tessy, France.
| | - H Baysson
- Délégation à la recherche clinique et à l'innovation, 74370 Metz-Tessy, France; Centre hospitalier Annecy-Genevois, 21, impasse des Ilettes, 74370 Metz-Tessy, France
| | - E Pineau-Blondel
- Pharmacie à usage intérieur, France; Centre hospitalier Annecy-Genevois, 21, impasse des Ilettes, 74370 Metz-Tessy, France
| | - J Berlioz
- Pharmacie à usage intérieur, France; Centre hospitalier Annecy-Genevois, 21, impasse des Ilettes, 74370 Metz-Tessy, France
| |
Collapse
|
27
|
Abrogoua DP, Koffi NO, Doffou E. [Pharmacist interventions on antibiotic prescriptions in outpatient pediatric unit in a teaching hospital of Côte d'Ivoire]. Ann Pharm Fr 2016; 74:380-8. [PMID: 26774460 DOI: 10.1016/j.pharma.2015.12.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2015] [Revised: 12/02/2015] [Accepted: 12/09/2015] [Indexed: 11/25/2022]
Abstract
OBJECTIVES The objectives of our study were to analyse the prescriptions of antibiotics and assessing the relevance of pharmacist interventions (PI) in outpatient consultations in a pediatric unit of a Teaching Hospital of Abidjan, Côte d'Ivoire. METHODS We conducted a cross-sectional descriptive study from May to December 2013. The analysis of antibiotic prescriptions was documented. The tool of PI classification validated by the French Society of Clinical Pharmacy was used. The PI rating was made by prescribers. This rating evolved from PI0 to PI3 depending on the severity of the clinical impact of the problem and to the severity of clinical consequences avoided by the PI. The relevance was evaluated by the PI acceptance rate by physicians and clinical evaluation of their impact. RESULTS Our study included 150 patients with a mean age of 11.75 months and a sex ratio (M/F) of 2. The amoxicillin-clavulanic acid (27.2 %) and amoxicillin (22.3 %) were the most prescribed antibiotics. Sixty-three drug-related problems (DRPs) were detected on the antibiotic prescriptions. They were non-optimal drug administration plan (88.9 %) and underdose (11.1 %). The amoxicillin-clavulanic acid (61.9 %) and josamycin (17.4 %) were the most affected by these DRPs. PI were related to the precision of modes of drug administration (88.9 %) and dose adjustments (11.1 %). The prescribers accepted 93.7 % of PIs. All accepted PIs was rated PI1 (significant clinical impact). CONCLUSIONS PIs performed on antibiotic prescription were relevant with a high rate of acceptance and a significant clinical impact.
Collapse
Affiliation(s)
- D P Abrogoua
- Laboratoire de pharmacie clinique et thérapeutique, UFR sciences pharmaceutiques et biologiques, université Félix Houphouët-Boigny, Abidjan, Côte d'Ivoire; Service de pharmacologie clinique, CHU de Cocody, Abidjan, Côte d'Ivoire.
| | - N O Koffi
- Laboratoire de pharmacie clinique et thérapeutique, UFR sciences pharmaceutiques et biologiques, université Félix Houphouët-Boigny, Abidjan, Côte d'Ivoire
| | - E Doffou
- Service pharmacie, CHU de Yopougon, Abidjan, Côte d'Ivoire
| |
Collapse
|
28
|
Lalande L, Bertin C, Rioufol C, Boleor P, Cabelguenne D. [Drug management of prisoners: Role of the pharmaceutical staff to ensure patient safety]. Ann Pharm Fr 2015; 74:146-53. [PMID: 26298847 DOI: 10.1016/j.pharma.2015.07.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2015] [Revised: 07/16/2015] [Accepted: 07/20/2015] [Indexed: 11/16/2022]
Abstract
OBJECTIVES In the prisons of Lyon, drug management of inmates implies cooperation between general practitioners, psychiatrists and pharmacists. All the medical prescriptions are reviewed by the pharmacists of the medical unit. The aim of this work was to synthesize the pharmaceutical interventions performed and show the implication of the pharmaceutical staff in detecting and handling prescribing errors. METHODS Pharmaceutical interventions performed between the 1st of June 2012 and the 31st December 2014 and entered in the Act-IP(®) database (SFPC) were retrospectively analyzed. RESULTS Among the 18,205 prescriptions reviewed, 4064 (22.3%) had a prescription error. The main problems encountered were by decreasing order of frequency: missing monitoring (15% of the interventions), lack of compliance (13%), over dosage (10%), lack of conformity with recommendations or consensus (8%). Interventions were accepted in 78% cases. Most prescribing errors implied medications of the central nervous system. Among the interventions, 8% were initiated by pharmacy technicians, mainly lack of compliance. CONCLUSIONS The pharmaceutical interventions reported reflected actions of securisation initiated by the pharmacists in cooperation with physicians: monitoring of patients taking antipsychotic medications or benzodiazepines maximal dosages. Besides, in this population with a high prevalence of psychiatric comorbidities and important suicide rate, detection of patients with default of compliance is one of the keys for drug optimization among these patients as it is an explanation for therapeutic failure.
Collapse
Affiliation(s)
- L Lalande
- Unité de pharmacie clinique en milieu carcéral, maison d'arrêt de Lyon-Corbas, groupement hospitalier Sud, hospices civils de Lyon, boulevard des Nations, 69960 Corbas, France.
| | - C Bertin
- Unité de pharmacie clinique en milieu carcéral, maison d'arrêt de Lyon-Corbas, groupement hospitalier Sud, hospices civils de Lyon, boulevard des Nations, 69960 Corbas, France
| | - C Rioufol
- Service de pharmacie, groupement hospitalier Sud, hospices civils de Lyon, bâtiment 3A, 165, chemin du Grand-Revoyet, 69310 Pierre-Bénite, France
| | - P Boleor
- Service de pharmacie, groupement hospitalier Sud, hospices civils de Lyon, bâtiment 3A, 165, chemin du Grand-Revoyet, 69310 Pierre-Bénite, France
| | - D Cabelguenne
- Unité de pharmacie clinique en milieu carcéral, maison d'arrêt de Lyon-Corbas, groupement hospitalier Sud, hospices civils de Lyon, boulevard des Nations, 69960 Corbas, France
| |
Collapse
|
29
|
Novais T, Cabelguenne D, Jolivet F, Nouvel M, Wallet F, Piriou V. [Technical criteria of central venous catheters: Anaesthesiologist/intensivist and pharmacist opinions]. Ann Pharm Fr 2015; 73:471-81. [PMID: 25980636 DOI: 10.1016/j.pharma.2015.04.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2015] [Revised: 03/31/2015] [Accepted: 04/10/2015] [Indexed: 11/23/2022]
Abstract
INTRODUCTION The lack of technical information from suppliers and from the literature, a wide variety of features and the absence of medical device reference document explain the difficulty for medical and pharmaceutical staffs to choose a central venous catheter (CVC). The aim of this study was to establish the specifications to choose a CVC according to the clinician needs. METHODS An analysis of suppliers' technical documentation and a literature review was performed to identify criteria and to collect them in a questionnaire to conduct semi-structured interviews between 1 pharmacist and 5 anaesthesiologists/intensivists. With these interviews, the technical criteria were classified according to their importance in 3 levels. RESULTS Thirteen technical criteria were identified after reading the technical documents and the literature. Among them, 8 were classified as "essential criteria" (level I) by the physicians: J-shaped guide, one clamp on each way, identified lumen, radiopacity, graduation every centimeter by 5 to 20 cm from the distal extremity, a length of 15 to 25 cm, a single-lumen catheter with a 14 to 16G way and a three-lumen catheter with 14 to 18G way. Finally, three criteria were classified as "intermediate criteria" (level II) and two as "optional criteria" (level III). CONCLUSIONS This collaborative approach allowed to reference new medical devices according to the clinicians needs. These CVC are a mean to respect guidelines for physicians and nurses and to secure the patient's care.
Collapse
|
30
|
Jacqueroux E, Lalande L, Meddour N, Papailhau C, Bernard E, Charroin C, Perichou J, Charpiat B, Locher F, Garcia S. [Analysis of the question-answer activity of a hospital pharmacy. Example of the handling of drug interactions]. Ann Pharm Fr 2014; 73:215-22. [PMID: 25499204 DOI: 10.1016/j.pharma.2014.10.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2014] [Revised: 10/23/2014] [Accepted: 10/30/2014] [Indexed: 11/15/2022]
Abstract
INTRODUCTION The medical care of patients generates questions among healthcare professionals. Some will necessitate an advanced research. The hospital pharmacist is at the interface between prescribers, caregivers and the medicines and is requested to answer these requests. Studies conducted in other countries showed that this question-answer activity represents a significant amount of time in daily work. In France, this topic was poorly explored. The objective of our work was to study the volume and the type of questions, the clinical situations, the time required, the medicines implicated and the sources of information used. MATERIALS AND METHODS A prospective study was conducted in the pharmacy of a university hospital. All the requests answered by the pharmaceutical team, which needed a specific research, analysis and writing of an answer were collected. RESULTS A hundred and one questions were analyzed, originating from doctors or medicals interns. Almost half concerned drug interactions, and among them, almost a fourth were not mentioned in the Summary of Product Characteristics of the medicines involved. A pharmaceutical advice was provided in 91.5% of the cases. Time dedicated to the research varied between less than 30 minutes and more than 8 hours. DISCUSSION AND CONCLUSION This study illustrates the question-answer activity of a hospital pharmacy, which is currently not taken into account as an indicator of pharmaceutical activity. A large part concerns analysis and management of drug interactions and requires a significant amount of pharmaceutical time.
Collapse
Affiliation(s)
- E Jacqueroux
- Centre de documentation et d'information pharmaceutiques, pharmacie centrale, hospices civils de Lyon, 69561 Saint-Genis Laval cedex, France
| | - L Lalande
- Service pharmacie, hôpital de la Croix-Rousse, hospices civils de Lyon, 69317 Lyon cedex 04, France
| | - N Meddour
- Service pharmacie, hôpital de la Croix-Rousse, hospices civils de Lyon, 69317 Lyon cedex 04, France
| | - C Papailhau
- Centre de documentation et d'information pharmaceutiques, pharmacie centrale, hospices civils de Lyon, 69561 Saint-Genis Laval cedex, France
| | - E Bernard
- Service pharmacie, hôpital de la Croix-Rousse, hospices civils de Lyon, 69317 Lyon cedex 04, France
| | - C Charroin
- Service pharmacie, hôpital de la Croix-Rousse, hospices civils de Lyon, 69317 Lyon cedex 04, France
| | - J Perichou
- Service pharmacie, hôpital de la Croix-Rousse, hospices civils de Lyon, 69317 Lyon cedex 04, France
| | - B Charpiat
- Service pharmacie, hôpital de la Croix-Rousse, hospices civils de Lyon, 69317 Lyon cedex 04, France
| | - F Locher
- Centre de documentation et d'information pharmaceutiques, pharmacie centrale, hospices civils de Lyon, 69561 Saint-Genis Laval cedex, France
| | - S Garcia
- Centre de documentation et d'information pharmaceutiques, pharmacie centrale, hospices civils de Lyon, 69561 Saint-Genis Laval cedex, France.
| |
Collapse
|
31
|
Parent G, Rose FX, Bedouch P, Conort O, Charpiat B, Juste M, Roubille R, Allenet B. [Pharmacists' interventions conducted by hospital pharmacists on psychotropic drugs pharmacotherapy]. Encephale 2014; 41:339-45. [PMID: 25523124 DOI: 10.1016/j.encep.2014.10.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2013] [Accepted: 06/12/2014] [Indexed: 10/24/2022]
Abstract
INTRODUCTION The French Society of Clinical Pharmacy (SFPC) through the special interest group "standardization and optimization of clinical pharmacy activities" stated that the study of pharmacists' interventions (PIs) conducted during prescription analysis was a priority. The SFPC developed an internet website named Act-IP(®) (http://www.sfpc.eu/fr/) where French speaking pharmacists were able to document PIs using a normalized codification. The objective of this study was to analyze medication-related problems linked to psychotropic drugs in hospital and to investigate PIs performed during prescription analysis. MATERIALS AND METHODS This is a multicenter, retrospective, observational study using PIs involving psychotropic medications recorded between September 2006 and February 2009 on the Act-IP(®) website. RESULTS Four thousand six hundred and twenty PIs recorded by 165 pharmacists in 57 hospitals were related to psychotropic drugs. Patients concerned by these drug-related problems were 64 years old on average. Seven categories of medication-related problems represented more than 69% of PIs (1.1-Non Conformity of the drug choice compared to the formulary; 4.1 Supratherapeutic dose; 5.3 Therapeutic redundancy; 6.2 Drug interaction (all levels of severity); 7.0 Adverse drug reaction; 8.3 Inappropriate drug form; 8.5 Inappropriate timing of administration). The PIs related to 9.2 Patient's non compliance, 2.0 Untreated indication and 3.2 Length of the treatment too short were infrequent (less than 1%). The most common type of intervention was the dose adjustment. Almost 45% of these PIs involved Zopiclone or Zolpidem prescription in elderly patients. Seven hundred and nine drug interactions were identified by pharmacists. The most common type of drug interaction considered the risk of cardiac arrhythmias due to antipsychotic medications. One hundred and thirty-three PIs concerned adverse drug reaction. The most frequent adverse drug reactions were a fall (36 PIs), hemorrhage/bleeding (32 PIs), drowsiness (12 PIs) and extrapyramidal syndrome (12 PIs). Antidepressant drugs were the greatest pharmacological class concerning adverse drug reaction. The overall acceptance rate was 57%. Eight hundred and seventy-four PIs (19%) were refused and 1111 (24%) were non-assessable. DISCUSSION PIs avoids drug-related problems, such as the polyprescription of benzodiazepine or supratherapeutic dose. However, few PIs concern compliance to therapy or polyprescription of antipsychotic drugs. These two categories of medication-related problems are known to be an issue in mental health therapy. The lack of guidelines describing mental health pathology (such as the HAS guideline) is an obstacle for performing evidence-based PIs. The lack of information describing the context of the prescription is a limitation of this study. In order to improve their practice, pharmacists have to focus more on the context in which patients are evolving, and to take into account its entire situation based on Anglo-Saxon approaches. A second way is to identify clinical settings where PIs are useful and to describe PIs needed. Doctors and pharmacists should get together and talk about these clinical situations and PIs, because some may be misunderstood or disapproved by prescribers. This collaboration could take the form of a thesaurus combining clinical situation and PIs. CONCLUSION It appears important for pharmacists to show their daily involvement in the quality of medical care. This feedback on medication problems encountered and PIs proposed should help prescribers to identify clinical situations at risk. Nevertheless, this study also suggests that progress is possible. Dialogue must allow pharmacists and physicians to delete misunderstandings about their practices.
Collapse
Affiliation(s)
- G Parent
- Service de pharmacie, EPSM Novillars-Besançon, rue du Dr-Charcot, 25220 Novillars, France
| | - F-X Rose
- Service de pharmacie, EPSM-Morbihan, rue de l'Hôpital, BP 10, 56826 Saint-Avé, France.
| | - P Bedouch
- CNRS/TIMC, IMAG UMR 5525, université Joseph-Fourier Grenoble 1, Themas, 38041 Grenoble, France; Pôle pharmacie, CHU de Grenoble, BP 217, 38043 Grenoble 09, France
| | - O Conort
- Service pharmacie, hôpital Cochin, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France
| | - B Charpiat
- Service pharmacie, hôpital de la Croix-Rousse, 103, Grande-Rue-de-la-Croix-Rousse, 69317 Lyon cedex 04, France
| | - M Juste
- Centre hospitalier Auban-Moët, 137, rue de l'Hôpital-Auban-Moët, 51200 Epernay, France
| | - R Roubille
- Service pharmacie, centre hospitalier Lucien-Hussel, Mont-Salomon, BP 127, 38209 Vienne cedex 9, France
| | - B Allenet
- CNRS/TIMC, IMAG UMR 5525, université Joseph-Fourier Grenoble 1, Themas, 38041 Grenoble, France; Pôle pharmacie, CHU de Grenoble, BP 217, 38043 Grenoble 09, France
| |
Collapse
|
32
|
Jean-Bart E, Faure R, Omrani S, Guilli T, Roubaud C, Krolak-Salmon P, Mouchoux C. [Role of clinical pharmacist in the therapeutical optimization in geriatric outpatient hospital]. Ann Pharm Fr 2014; 72:184-93. [PMID: 24780834 DOI: 10.1016/j.pharma.2013.12.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2013] [Revised: 12/14/2013] [Accepted: 12/19/2013] [Indexed: 10/25/2022]
Abstract
SETTING Cares in outpatient hospital for elderly patients is a period of interest for multidisciplinary reassessment and pharmaceutical care of the prescription. The objective is to present the implementation of the pharmaceutical care activity at the outpatient hospital. METHODS Between August and October 2011, elderly patients hospitalized in the outpatient hospital for a brief appraisal had a pharmaceutical care. The clinician introduced pharmaceutical reviews in the synthesis letter for general practitioner. An analysis of the activity was carried out over 3 months. RESULTS A pharmaceutical care had been realized for 67 patients, mean age of 81.7 years. Among medical related problems identified, 39.6% were for potentially unnecessary medication. A stop was proposed for 44% of pharmaceutical interventions. A total of 91 pharmaceutical interventions and 13 recommendations were made and 34% of patients had potentially inappropriate medication. CONCLUSION According to the objective to reduce the therapeutics contributing to the iatrogenesis, this approach allowed us to undertake a multidisciplinary collaboration oriented toward the relay between hospital and city cares.
Collapse
Affiliation(s)
- E Jean-Bart
- Pharmacie, hôpital des Charpennes, hospices civils de Lyon, 27, rue Gabriel-Péri, 69100 Villeurbanne, France.
| | - R Faure
- Pharmacie, hôpital des Charpennes, hospices civils de Lyon, 27, rue Gabriel-Péri, 69100 Villeurbanne, France
| | - S Omrani
- Pharmacie, hôpital des Charpennes, hospices civils de Lyon, 27, rue Gabriel-Péri, 69100 Villeurbanne, France
| | - T Guilli
- Pharmacie, hôpital des Charpennes, hospices civils de Lyon, 27, rue Gabriel-Péri, 69100 Villeurbanne, France
| | - C Roubaud
- Centre mémoire, recherche et ressource de Lyon, hôpital des Charpennes, hospices civils de Lyon, 69100 Villeurbanne,France
| | - P Krolak-Salmon
- Centre mémoire, recherche et ressource de Lyon, hôpital des Charpennes, hospices civils de Lyon, 69100 Villeurbanne,France; Université Claude-Bernard Lyon-1, 69373 Lyon, France; Inserm, U1028, CNRS, UMR5292, centre de recherche en neurosciences, 69500 Bron, France; Centre de recherche clinique « vieillissement, cerveau, fragilité », hôpital des Charpennes, hospices civils de Lyon, 69100 Villeurbanne, France
| | - C Mouchoux
- Pharmacie, hôpital des Charpennes, hospices civils de Lyon, 27, rue Gabriel-Péri, 69100 Villeurbanne, France; Université Claude-Bernard Lyon-1, 69373 Lyon, France; Inserm, U1028, CNRS, UMR5292, centre de recherche en neurosciences, 69500 Bron, France; Centre de recherche clinique « vieillissement, cerveau, fragilité », hôpital des Charpennes, hospices civils de Lyon, 69100 Villeurbanne, France
| |
Collapse
|
33
|
Guérin A, Thibault M, Nguyen C, Lebel D, Bussières JF. [Steps aimed at upgrading a pharmaceutical care sector: the case of surgery]. Ann Pharm Fr 2014; 72:267-86. [PMID: 24997888 DOI: 10.1016/j.pharma.2013.12.012] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2013] [Revised: 12/20/2013] [Accepted: 12/24/2013] [Indexed: 11/19/2022]
Abstract
BACKGROUND While the concept of clinical pharmacy was developed in the 1960s, clinical programs are characterized by their great variety and disparity when it comes to the presence of pharmacists in healthcare sectors. PURPOSE This article aims to describe a method in which pharmaceutical care sectors in healthcare facilities can be upgraded. METHODS This is a descriptive study supporting the upgrade of pharmaceutical care practiced in the surgery sector of a 500-bed mother-child university hospital center, the CHU Sainte-Justine. The pharmacy department employs more than 70 healthcare professionals. The study involved these proposed upgrading steps: firstly, a review of the literature; secondly, a description of the profile of the sector; thirdly, a description of the upgrading of pharmacist practice in surgery. RESULTS A total of 137 articles were compiled, seven of which were selected to evaluate the impact and eight a description of the pharmacist's role in surgery. The authors did not identify any particular pharmaceutical activity based on very good quality data (A). However, there were five based on good quality data (B) and seven that lacked adequate proof (C, D) in relation to the practice of surgery. Nevertheless, a number of other authors described the development of the pharmacist's clinical role in surgery. CONCLUSION There are few data on the impact of pharmacists in surgery. This descriptive study proposes a number of steps aimed at upgrading pharmaceutical care within a Quebec university hospital center.
Collapse
Affiliation(s)
- A Guérin
- Département de pharmacie et unité de recherche en pratique pharmaceutique, CHU Sainte-Justine, 3175, chemin de la Côte-Sainte-Catherine, H3T 1C5 Montréal, Québec, Canada
| | - M Thibault
- Département de pharmacie et unité de recherche en pratique pharmaceutique, CHU Sainte-Justine, 3175, chemin de la Côte-Sainte-Catherine, H3T 1C5 Montréal, Québec, Canada
| | - C Nguyen
- Département de pharmacie et unité de recherche en pratique pharmaceutique, CHU Sainte-Justine, 3175, chemin de la Côte-Sainte-Catherine, H3T 1C5 Montréal, Québec, Canada
| | - D Lebel
- Département de pharmacie et unité de recherche en pratique pharmaceutique, CHU Sainte-Justine, 3175, chemin de la Côte-Sainte-Catherine, H3T 1C5 Montréal, Québec, Canada
| | - J-F Bussières
- Département de pharmacie et unité de recherche en pratique pharmaceutique, CHU Sainte-Justine, 3175, chemin de la Côte-Sainte-Catherine, H3T 1C5 Montréal, Québec, Canada; Faculté de pharmacie, université de Montréal, 2900, Édouard Montpetit, H3T 1J4 Montréal, Québec, Canada.
| |
Collapse
|
34
|
Moch C, Pivot C, Floccard B, Rimmelé T, Paillet C. [Integration of a hospital pharmacist in the ICU]. Ann Pharm Fr 2014; 72:90-4. [PMID: 24630309 DOI: 10.1016/j.pharma.2013.11.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2013] [Revised: 11/20/2013] [Accepted: 11/21/2013] [Indexed: 10/25/2022]
Abstract
The French regulatory system strongly encourages strict regulation of health products' production and distribution, especially concerning risk management and economic aspects. An ICU is an unusual environment for a local pharmacy practice (a nurse for every 2.5 patients, continuous adaptation of therapeutics…). However, a literature review reports interesting data concerning risk management and economics. This article aims to relate the experience of a pharmacist integration in a French teaching hospital ICU (half-time position).
Collapse
Affiliation(s)
- C Moch
- Service pharmacie, groupement hospitalier Édouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Lyon, France.
| | - C Pivot
- Service pharmacie, groupement hospitalier Édouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Lyon, France
| | - B Floccard
- Service d'anesthésie-réanimation, groupement hospitalier Édouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Lyon, France
| | - T Rimmelé
- Service d'anesthésie-réanimation, groupement hospitalier Édouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Lyon, France
| | - C Paillet
- Service pharmacie, groupement hospitalier Édouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Lyon, France
| |
Collapse
|